medigraphic.com
Colegio de Medicina Interna de México.

2021, Number 6

<< Back Next >>

Med Int Mex 2021; 37 (6)

Prevalence of depression and related factors in patients from a program for the integral care of chronic obstructive pulmonary disease

Quintero-González LA, Rosas-Duarte S

Language: Spanish
References: 29
Page: 929-937
PDF size: 194.13 Kb.


ABSTRACT

Background: Depression is a known comorbidity of chronic obstructive pulmonary disease, although the diagnosis is not frequent.
Objective: To determine the prevalence of depression and associated factors in patients with chronic obstructive pulmonary disease in a comprehensive care program.
Materials and Methods: A cross-sectional study of 322 chronic obstructive pulmonary disease patients from a comprehensive care program in Colombia was conducted in 2017. Sociodemographic, clinical and paraclinical factors were obtained from the program’s monitoring bases. The PHQ9 questionnaire evaluated the presence of depression. The logistic regression was determined to estimate OR and confidence intervals 95% (CI).
Results: The prevalence of depression was 35.4% (n = 114) and anxiety was 10.2% (n = 33). Chronic obstructive pulmonary disease patients were mostly men (63%), average age was of 75 years. The risk factor for chronic obstructive pulmonary disease was tobacco (58%); however, only 2% had active smoking; 41% had exacerbations and 15.2% hospitalizations. The multivariate analysis showed factors associated with the presence of depression: female sex (RP: 1.37 95%CI 1.04-1.81), and exacerbations (RP: 2.05 95%CI 1.16-3.62).
Conclusions: In chronic obstructive pulmonary disease patients, depression was associated with the female sex, and hospitalizations due to respiratory causes. We recommend systematically including the evaluation of depression in the follow-up of these patients.


REFERENCES

  1. WHO. Enfermedad pulmonar obstructiva crónica (EPOC). Nota informativa [internet]. Organización Mundial de la Salud. 2017. 2017; Available from: https://www.who.int/ es/news-room/fact-sheets/detail/chronic-obstructivepulmonary- disease-(copd).

  2. Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008; 133: 343-9. doi: 10.1378/ chest.07-1361.

  3. Nevárez-Sida A, Castro-Bucio AJ, García-Contreras F, Cisneros-González N. Costos médicos directos en pacientes con enfermedad pulmonar obstructiva crónica en México. Value Heal Reg Issues 2017; 14: 9-14. http://dx.doi. org/10.1016/j.vhri.2017.03.004.

  4. Masa JF, Sobradillo V, Villasante C, Jiménez-Ruiz CA, Fernández-Fau L, Viejo JL, et al. Costes de la EPOC en España. Estimación a partir de un estudio epidemiológico poblacional. Arch Bronconeumol 2004; 40 (2): 72-9. DOI: 10.1016/S0300-2896(04)75476-9.

  5. Cerezo Lajas A, Puente-Maestu L, De Miguel-Díez J. Relevance of comorbidity in chronic obstructive pulmonary disease (COPD). Rev Patol Respir 2019; 22 (3): 81-3.

  6. Montserrat-Capdevila J, Godoy P, Marsal JR, Ortega M, Pifarré J, Alsedà M, et al. Mental disorders in chronic obstructive pulmonary diseases. Perspect Psychiatr Care 2018; 54 (3): 398-404. doi: 10.1111/ppc.12274.

  7. Guillien A, Laurent L, Soumagne T, Puyraveau M, Laplante JJ, Andujar P, et al. Anxiety and depression among dairy farmers: The impact of COPD. Int J Chron Obstruct Pulmon Dis 2018; 13: 1-9. doi: 10.2147/COPD.S143883.

  8. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 2006; 100 (10): 1767-74. doi: 10.1016/j.rmed.2006.01.026.

  9. Montserrat-Capdevila J, Godoy P, Marsal JR, Barbé F, Pifarré J, Alsedà M, et al. Overview of the impact of depression and anxiety in chronic obstructive pulmonary disease. Lung 2017; 195 (1): 77-85. doi: 10.1007/s00408-016-9966-0.

  10. Agarwal A, Batra S, Prasad R, Verma A, Jilani AQ, Kant S. A study on the prevalence of depression and the severity of depression in patients of chronic obstructive pulmonary disease in a semi-urban Indian population. Monaldi Arch Chest Dis 2018; 88 (1): 54-60. doi: 10.4081/ monaldi.2018.902.

  11. Xiao T, Qiu H, Chen Y, Zhou X, Wu K, Ruan X, et al. Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: A cross-sectional study. BMC Psychiatry 2018; 18 (1): 89. doi: 10.1186/s12888-018-1671-5.

  12. Matte DL, Pizzichini MMM, Hoepers ATC, Diaz AP, Karloh M, Dias M, et al. Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies. Respir Med 2016; 117: 154-61. http://dx.doi.org/10.1016/j. rmed.2016.06.006.

  13. Tomas-Baader M, Molina JL, Venezian S, Rojas C, Farías R, Fierro-Freixenet C, et al. Validación y utilidad de la encuesta PHQ-9 (Patient Health Questionnaire) en el diagnóstico de depresión en pacientes usuarios de atención primaria en Chile. Rev Chil Neuropsiquiatr 2012; 50 (1): 10-22. http:// dx.doi.org/10.4067/S0717-92272012000100002.

  14. Cassiani-Miranda CA, Cuadros-Cruz AK, Torres-Pinzón H, Scoppetta O, Pinzón-Tarrazona JH, López-Fuentes WY, et al. Validity of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adult primary care users in Bucaramanga, Colombia. Rev Colomb Psiquiatr 2021; 50: 11-21. https://doi.org/10.1016/j.rcp.2019.09.001.

  15. Cassiani-Miranda CA, Vargas-Hernández MC, Pérez-Aníbal E, Herazo-Bustos MI, Hernández-Carrillo M. Confiabilidad y dimensión del cuestionario de salud del paciente (PHQ-9) para la detección de síntomas de depresión en estudiantes de ciencias de la salud en Cartagena, 2014. Biomédica 2017; 37: 112-20. https://doi.org/10.7705/biomedica.v37i0.3221.

  16. Saldivia S, Aslan J, Cova F, Vicente B, Inostroza C, Rincón P. Propiedades psicométricas del PHQ-9 (Patient Health Questionnaire) en centros de atención primaria de Chile. Rev Med Chil 2019; 147 (1): 53-60.

  17. Schueller SM, Kwasny MJ, Dear BF, Titov N, Mohr DC. Cut points on the Patient Health Questionnaire (PHQ-9) that predict response to cognitive-behavioral treatments for depression. Gen Hosp Psychiatry 2015; 37 (5): 470-5. http://dx.doi.org/10.1016/j.genhosppsych.2015.05.009.

  18. González-Gutiérrez MV, Guerrero Velázquez J, Morales García C, Casas Maldonado F, Gómez Jiménez FJ, González Vargas F. Predictive model for anxiety and depression in Spanish patients with stable chronic obstructive pulmonary disease. Arch Bronconeumol 2016; 52 (3): 151-7. doi: 10.1016/j.arbres.2015.09.003.

  19. Hanania NA, Müllerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EFM, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 2011; 183 (5): 604-11. doi: 10.1164/ rccm.201003-0472OC.

  20. Ministerio de salud Colombia. Boletín de salud mental Depresión. Subdirección de Enfermedades No Transmisibles. Boletín Salud Ment 2017; 2: 0-16.

  21. Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: State of the science. Hear Lung J Acute Crit Care 2009; 38 (1): 34-47. http://dx.doi.org/10.1016/j.hrtlng.2008.02.005.

  22. Varol Y, Anar C, Çimen P, Ünlü M, Halilçolar H, Güçlü SZ. Sex-related differences in COPD assessment test scores of COPD populations with or without significant anxiety and/ or depression. Turkish J Med Sci 2017; 47 (1): 61-8. doi: 10.3906/sag-1509-60.

  23. Lee JH, Park MA, Park MJ, Jo YS. Clinical characteristics and related risk factors of depression in patients with early COPD. Int J COPD 2018; 13: 1583-90. doi: 10.2147/ COPD.S157165.

  24. Xu K, Li X. Risk factors for depression in patients with chronic obstructive pulmonary disease. Med Sci Monit 2018; 24: 1417-23. doi: 10.12659/MSM.904969.

  25. Akasheh N, Byrne D, Coss P, Conway R, Cournane S, O’Riordan D, et al. Lung function and outcomes in emergency medical admissions. Eur J Intern Med 2019; 59: 34-8. https://doi.org/10.1016/j.ejim.2018.09.010.

  26. Iyer AS, Bhatt SP, Garner JJ, Wells JM, Trevor JL, Patel NM, et al. Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2016; 13 (2): 197-203. doi: 10.1513/ AnnalsATS.201507-439OC.

  27. Lecheler L, Richter M, Franzen DP, Rampini SK, Cheetham M, Jenewein J, et al. The frequent and underrecognised co-occurrence of acute exacerbated COPD and depression warrants screening: A systematic review. Eur Respir Rev 2017; 26 (144). http://dx.doi.org/10.1183/16000617.0026-2017.

  28. Soler-Cataluña JJ, Sauleda J, Valdés L, Marín P, Agüero R, Pérez M, et al. Prevalencia y percepción de la variabilidad diaria de los síntomas en pacientes con enfermedad pulmonar obstructiva crónica estable en España. Arch Bronconeumol 2016; 52 (6): 308-15. DOI: 10.1016/j.arbres.2015.11.010.

  29. Thapa N, Maharjan M, Shrestha TM, Gauchan S, Pun P, Thapa YB. Anxiety and depression among patients with chronic obstructive pulmonary disease and general population in rural Nepal. BMC Psychiatry. 2017; 17: 397. doi: 10.1186/s12888-017-1550-5.




2020     |     www.medigraphic.com